Top Markets
Coin of the day
Heyu Biological Technology Corporation Heyu Biological Technology Corporation

Heyu Biological Technology Corporation

HYBT
Rank in Stocks #27959
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on... Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease. The company, incorporated in 1987 and headquartered in Xiamen, People's Republic of China, was formerly known as Pacific WebWorks, Inc., before adopting its current name, Heyu Biological Technology Corporation, in June 2018.
Share Price
$0.2853
Last synced: 2023-12-15
Market Cap
$29.46M
Change (1 day)
4.70%
Change (1 year)
0.00%
Country
CN
Trade Heyu Biological Technology Corporation (HYBT)

Category

Revenue for Heyu Biological Technology Corporation (HYBT)
Revenue in Aug 2026 TTM: 0
According to Heyu Biological Technology Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Heyu Biological Technology Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
- -
DE